Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence

INTRODUCTION: Primate and rodent models show that peroxisome proliferator-activated receptor-alpha (PPAR-α) ligands, including fibrate medications, reduce nicotine reinforcement, reward, and related effects. We tested fenofibrate, the most common US Food and Drug Administration-approved fibrate for...

Full description

Saved in:
Bibliographic Details
Published in:Nicotine Tob Res
Main Authors: Perkins, Kenneth A., Karelitz, Joshua L., Michael, Valerie C., Fromuth, Margaret, Conklin, Cynthia A., Chengappa, K. N. Roy, Hope, Chris, Lerman, Caryn
Format: Artigo
Language:Inglês
Published: Oxford University Press 2016
Subjects:
Original Investigation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4881827/
https://ncbi.nlm.nih.gov/pubmed/25895948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ntr/ntv085
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items